CVC Capital Partners/Temasek $2 billion acquisition of Alvogen

5/6/2015
Private acquisition

$ 2 billion

Completed

5/6/2015


Overview:

  • CVC Capital Partners and Temasek have acquired a majority stake in Alvogen from Pamplona Capital Management in a transaction worth $2 billion.

Rani Mehta - Journalist 

Jurisdictions:

United States
Luxembourg

Deal type:

Private acquisition

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences


Firms:

Party: Pamplona Capital Management (Seller)


Party: CVC Capital Partners (Acquirer)

Party: Vatera Healthcare Partners (Acquirer)


Party: Pamplona Capital Management (Seller)


Party: Pamplona Capital Management (Seller)

Party: Alvogen (Target)


Party: CVC Capital Partners (Acquirer)

Party: Vatera Healthcare Partners (Acquirer)